Gilead Rips Merck's New Bid To Restore $2.5B Patent Verdict
Gilead Sciences Inc. urged the Federal Circuit on Thursday to nix a Merck & Co. subsidiary's bid for the full court to review a panel decision that wiped out a $2.5...To view the full article, register now.
Already a subscriber? Click here to view full article